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Background
In cancer cells, transcriptional gene silencing has been
associated with genetic and epigenetic defects. The disrup-
tion of DNA methylation patterns and covalent histone
marks has been associated with cancer development. In
non-neoplastic cells the multifunctional CCCTC-binding
factor (CTCF) can serve as a barrier against the spread of
DNA methylation and histone repressive marks into pro-
moter regions of tumor suppressor genes such as BRCA1,
Rb, p16 and p53. The absence of CTCF has been related
with its epigenetic gene silencing. Until recently, micro-
RNA (miRNA) gene silencing was not well understood. In
particular, miR- 125b1 has been suggested to be a miRNA
with tumor suppressor activity, and it has been shown to
be deregulated in various human cancers.
Materials and methods
As a first approach we performed a functional promoter
characterization of a CpG island proximal to the transcrip-
tion star site of the miR-125b1 gene. After, demonstrating
the promoter activity, we focused in evaluating the DNA
methylation of this region in cancer cell lines as well as in
normal tissues and gynecological tumor samples. We
determine the effect of DNA methylation at the CpG
island of miR-125b1 on the expression of this gene, we
performed a qRT-PCR assay. In addition, we analyzed the
association of CTCF and covalent histone modifications at
the miR-125b1 locus.
Results
Our results demonstrated the dissociation of CTCF at the
miR-125b1 gene promoter in breast cancer cell lines and
in gynecological cancers. The disruption of CTCF in
breast cancer cells correlated with the incorporation of
repressive histone marks such H3K9me3 and H3K27me3
as well as with aberrant DNA methylation patterns. We
observed a significant reduction on the expression of miR-
125b1 in cancer cells in comparison with controls, sug-
gesting that DNA methylation and repressive histone
marks at the CpG island might reduce miR-125b1 expres-
sion. These effects were observed in other gynecological
cancers, including ovarian and cervical tumors.
Conclusions
A reduction of miR-125b1 expression in cancers, corre-
lated with methylation, repressive histone marks and loss
of CTCF binding at the promoter region.
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